213 related articles for article (PubMed ID: 6606041)
1. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
[TBL] [Abstract][Full Text] [Related]
2. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of the in vivo antinuclear antibody phenomenon.
Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
[TBL] [Abstract][Full Text] [Related]
4. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
[TBL] [Abstract][Full Text] [Related]
5. [Nucleolar, homogeneous and peripheral fluorescence of epidermal nuclei in direct immunofluorescence: 4 cases (author's transl)].
Morel P; Allègre P; Civatte J
Ann Dermatol Venereol; 1979 Apr; 106(4):361-4. PubMed ID: 384881
[TBL] [Abstract][Full Text] [Related]
6. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.
Reimer G; Huschka U; Keller J; Kammerer R; Hornstein OP
Br J Dermatol; 1983 Jul; 109(1):27-36. PubMed ID: 6344904
[TBL] [Abstract][Full Text] [Related]
7. Epidermal nucleolar IgG deposition in clinically normal skin: clinical and serologic features of eight patients.
Prystowsky SD; Gilliam JN; Tuffanelli DL
Arch Dermatol; 1978 Apr; 114(4):536-8. PubMed ID: 348111
[TBL] [Abstract][Full Text] [Related]
8. Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.
Shu S; Provost T; Croxdale MB; Reichlin M; Beutner EH
Clin Exp Immunol; 1977 Feb; 27(2):238-44. PubMed ID: 300310
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory characteristics of patients with speckled pattern antinuclear antibodies.
McMillan SA; Fay AC; Taggart AJ; McCrea JD; Roberts SD; Boyd MW; Nelson JK; Haire M
Ulster Med J; 1986 Oct; 55(2):112-7. PubMed ID: 3492803
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of antinuclear antibodies.
Meryhew NL; Messner RP; Tan EM
J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
[TBL] [Abstract][Full Text] [Related]
12. Direct immunofluorescent findings in scleroderma syndromes.
Connolly SM; Winkelmann RK
Acta Derm Venereol; 1981; 61(1):29-36. PubMed ID: 6164211
[TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
Kleinsmith DM; Heinzerling RH; Burnham TK
Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
15. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
16. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
17. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
Morel P; Peltier AP; Allegre P; Civatte J
Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
[TBL] [Abstract][Full Text] [Related]
18. [Antinuclear antibodies, patterns and characteristics obtained by immunofluorescence. The importance of the IgA, IgM and IgG isotypes].
Arcavi M; Dadone J
Medicina (B Aires); 2009; 69(5):502-6. PubMed ID: 19897433
[TBL] [Abstract][Full Text] [Related]
19. Use of human skin to demonstrate antinuclear antibodies in lepromatous leprosy patients.
Lamas-Robles C; González-Mendoza A; Pérez-Suárez G; Mejía-Arreguín S
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):373-7. PubMed ID: 3876399
[TBL] [Abstract][Full Text] [Related]
20. Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family.
Ramos-Niembro F; Alarcon-Segovia D
J Rheumatol; 1978; 5(4):433-40. PubMed ID: 310886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
